Extendicare (TSE:EXE) Hits New 12-Month High After Analyst Upgrade

Extendicare Inc. (TSE:EXEGet Free Report) hit a new 52-week high during mid-day trading on Monday after BMO Capital Markets raised their price target on the stock from C$24.00 to C$30.00. The stock traded as high as C$27.44 and last traded at C$26.56, with a volume of 57784 shares. The stock had previously closed at C$26.58.

A number of other equities analysts have also recently issued reports on EXE. National Bank Financial increased their price objective on shares of Extendicare from C$24.50 to C$29.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Canadian Imperial Bank of Commerce increased their price target on Extendicare from C$18.00 to C$22.00 in a report on Thursday, November 13th. Canaccord Genuity Group raised their price objective on Extendicare from C$20.00 to C$22.50 in a research note on Thursday, December 4th. TD Securities upped their target price on Extendicare from C$15.00 to C$19.00 in a research report on Thursday, November 13th. Finally, Royal Bank Of Canada upgraded Extendicare from a “hold” rating to a “moderate buy” rating and increased their target price for the stock from C$15.00 to C$25.00 in a report on Thursday, December 4th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of C$25.36.

Check Out Our Latest Stock Analysis on Extendicare

Extendicare Trading Down 0.8%

The company has a debt-to-equity ratio of 91.85, a current ratio of 1.37 and a quick ratio of 0.98. The firm’s fifty day moving average is C$23.25 and its two-hundred day moving average is C$18.99. The firm has a market capitalization of C$2.48 billion, a PE ratio of 23.56 and a beta of 1.30.

Extendicare (TSE:EXEGet Free Report) last posted its earnings results on Thursday, February 26th. The company reported C$0.29 EPS for the quarter. The firm had revenue of C$462.03 million for the quarter. Extendicare had a net margin of 5.82% and a return on equity of 47.65%. On average, equities analysts predict that Extendicare Inc. will post 0.6134729 EPS for the current fiscal year.

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Featured Articles

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.